Empagliflozin
medicationSGLT2 inhibitor (brand name: Jardiance) for type 2 diabetes. Shows cardiovascular and kidney protection benefits. Used in some longevity protocols.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Empagliflozin to your stack to report effects
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Not specified
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Nervous Activity in Patients With Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Not specified in available details
No reports yet
Be the first to report this effect and help the community.
Add Empagliflozin to your stack to report effects
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Not specified
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research (2 studies)
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Nervous Activity in Patients With Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Not specified in available details
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Not specified
Community updates
No updates yet for this supplement.
Be the first to share your experience!